# Vicore Pharma (VCRE) — Overview

VCRE · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/vcre

## Price

Last close $9.09 on Oct 15, 2026. 52-week range $8.66 – $16.25.

## Company profile

Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $426,004.94 |
| Revenue (quarter) | $228,113.76 |
| Revenue growth (year over year) | 23.96% |
| Gross profit (trailing twelve months) | $426,004.94 |
| Gross margin | 100.00% |
| Net income (trailing twelve months) | −$53.8M |
| Net income (quarter) | −$14.7M |
| Net income growth (year over year) | -21.10% |
| Net margin | -12623.77% |
| Return on equity | 0.00% |
| EPS (trailing twelve months) | −$2.05 |
| Book value per share | $0.00 |
| P/E (trailing twelve months) | — |
| Price to book | 2.9 |
| Debt to assets | 8.20% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Vicore Pharma (VCRE) profitable?

No. Vicore Pharma reported a net loss of $53.8M over the trailing twelve months.

### How much revenue does Vicore Pharma (VCRE) make?

Vicore Pharma generated $426,004.94 in revenue over the trailing twelve months, up 23.96% year over year.

### How do I buy stock in Vicore Pharma (VCRE)?

VCRE trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).